Speaker illustration

Doctor Berlinde von Kemp

University Hospital (UZ) Brussels, Brussels (Belgium)

Dr. Berlinde von Kemp has a particular expertise in cardio-oncology after additional training at Sorbonne University (Paris, FR), as well as in heart failure, having graduated from PCHF London in 2024. She is the primary point of contact for the cardio-oncology outpatient clinic at Universitair Ziekenhuis Brussel since 2021. Consultations are conducted in a multidisciplinary approach alongside the Oncology, Haematology and Radiotherapy departments. She is a core member of the Belgian Council of Cardio-Oncology as well as active member of the Belgian Working Group of Heart Failure. Furthermore, dr. von Kemp is an experienced echocardiographist with special interest in cardiovascular disease in women and gender-sensitive healthcare.

Does HFpEF represent a risk factor and a marker of cardiotoxicity in patients undergoing cancer treatment?

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardiotoxicity and development of heart failure

Thumbnail

Normal left ventricular ejection fraction and impaired longitudinal strain: is this significant cardiotoxicity? - case presentation

Event: ESC Congress 2023

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session: Guidelines in Practice: cardiac imaging in cancer and the 2022 ESC Guidelines on Cardio-Oncology

Thumbnail